Use of nonhuman primates for assaying tumorigenicity of viral-vaccine cell substrates.
D000818:Animals; D000961:Antilymphocyte Serum; D002277:Carcinoma / Q000276:immunology; D002460:Cell Line; D046508:Culture Techniques; D004372:Ducks; D005333:Fetus; D000882:Haplorhini; D006367:HeLa Cells; D006258:Head and Neck Neoplasms / Q000276:immunology; D006801:Humans; D007136:Immunoglobulins; D007668:Kidney; D007822:Laryngeal Neoplasms; D008168:Lung / Q000276:immunology; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000276:immunology*; D011817:Rabbits; D016038:Skin Transplantation; D013950:Thymus Gland / Q000166:cytology / Q000276:immunology; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D014765:Viral Vaccines; D014776:Virus Cultivation
D000961:Antilymphocyte Serum; D007136:Immunoglobulins; D014765:Viral Vaccines